Over £163 million potentially saved for the NHS*1

Use our cost savings calculator to find out how much your ICB / HB could save by prescribing Trustsaver products.

Free cost savings calculator

over

£

million

Trustsaver® is a portfolio of high-quality branded products that offer you the potential to make significant acquisition cost savings vs competitor products.

Trustsaver® prides itself on directly supporting Medicines Management in the NHS to realise savings in their ICB / HB and to positively impact prescribing budgets.

Trustsaver® is brought to you by Galen, a Northern Ireland based global pharmaceutical company selling medicines worldwide. Our products are high quality and can be prescribed with confidence.

Find out more about Galen
References
References

  1. Data on File 01. Galen Limited

*The savings estimate refers to product acquisition costs. It has been calculated using PCA data for the Trustsaver® products since its launch in 2010 and reflects the theoretical difference in costs, had 100% of prescriptions been for the market-leading competitor instead (excludes latest product additions and includes past Trustsaver® products).1

By using this website, you agree to the use of cookies as described in our Privacy Policy.

Accept

Designed to help prescribing budgets go further

I am a Healthcare Professional

I am a Member of the Public
The Trustsaver® portfolio of products includes:
  • ClinOpticTM HA 0.1% Eye Drops (includes sodium hyaluronate)
  • ClinOpticTM HA 0.21% Eye Drops (includes sodium hyaluronate)
  • Salcrozine 500 mg gastro-resistant tablets (mesalazine)
  • Salcrozine 1000 mg gastro-resistant tablets (mesalazine)
  • Salivix® Spray (ingredients include malic acid, xylitol and sodium fluoride)
  • Thorens® 10,000 I.U./ml oral drops, solution (colecalciferol)
  • Thorens® 25,000 I.U./2.5ml oral solution (colecalciferol)
  • Zemtard® XL (diltiazem hydrochloride)

Galen Limited is a privately-owned pharmaceutical sales and marketing company established in 1968. By combining innovation in product development with competitive pricing, Galen aims to work in partnership with healthcare professionals and patients, a major factor in the company's success to date. If you would like to find out more about Galen, its products or information on the disease areas we cover, please visit www.galen-pharma.com.